UveitisCSG retweeted
The Multimodal Imaging in Uveitis (MUV) Taskforce has published Report 15: Evidence and Consensus-Based Imaging Guidelines in Cytomegalovirus Retinitis, now available in Ophthalmology Retina.
ophthalmologyretina.org/arti…
#IUSG #MUVTaskforce #CytomegalovirusRetinitis #CMV
UveitisCSG retweeted
🇮🇹 Join IUSG’s Global Case Conference 7: representative uveitis cases from Italy!
📅 Sat 12 Sept
🕐 13:00–14:30 BST | 14:00–15:30 CEST
Un’occasione per imparare insieme!
🔗 Register here: zoom.us/webinar/register/WN_…
#Uveitis #Ophthalmology @iusg_official @UNIMORE_univ #MedEd #BlauSyndrome #Lymphoma #Autoimmune
UveitisCSG retweeted
In this week's IUSG Sunday Musings, Prof. @andrewdick4 shares five reflections drawn from his transition from internal medicine into ophthalmology and decades of clinical practice. #IUSG #Uveitis
Don't miss our next webinar, 'The Rise and Fall of White Dot Syndromes: From Descriptive Phenotypes to Mechanism-Based Classification', on 2 September at 20:00 CEST.
It's free to join!
Sign up here: ow.ly/xzys50ZAKbG
#Euretina #MedicalEducation #Ophthalmology #Webinar
UveitisCSG retweeted
In this week's IUSG Sunday Musings, Dr. James T. Rosenbaum shares the clinical maxims he's used for over 40 years to help patients understand their uveitis and its treatment.
#IUSG #Uveitis #Ophthalmology #OcularImmunology #ClinicalWisdom #MaximizingMaxims #SundayMusings
UveitisCSG retweeted
The IUSG EMERGE program was founded to support early-stage clinician researchers by matching an experienced mentor who can guide them to develop and complete a research project leading to a peer reviewed publication.
#IUSG #IUSGEmerge
Don't miss our next webinar, 'The Rise and Fall of White Dot Syndromes: From Descriptive Phenotypes to Mechanism-Based Classification', on 2 September at 20:00 CEST.
It's free to join!
Sign up here: ow.ly/xzys50ZAKbG
#Euretina #MedicalEducation #Ophthalmology #Webinar
UveitisCSG retweeted
A lesson from #ISU2026: progress in #uveitis does not happen in silos. Countries see different disease patterns, and no single specialty owns ocular inflammation. Constructive disagreement is where collaboration begins.
Some reflections:
linkedin.com/posts/nimaghadi…
━━━━━━━ ◦ ❖ ◦ ━━━━━━━
@IUSG9 #Uveitis @UveitisSociety @uveitis_auvea @OliviasVision @IOIS_Uveitis @UveitisCSG @UveitisArg @YoungUveitis #OcularInflammation
UveitisCSG retweeted
Uveitis specialists often think far beyond the eye. Diagnosing #ocular #inflammation requires a thorough review of systems, knowledge of systemic disease, and careful clinical reasoning. #YOInfo ow.ly/6gVf50ZlLj2
UveitisCSG retweeted
Herpesvirus Retinitis by Immune Status: Clinical Phenotypes and Predictors of Retinal Detachment and Severe Visual Impairment
ow.ly/7Lf750Zb5Ya
#ophthalmology #retina
UveitisCSG retweeted
Time to retire “White Dot Syndromes”.
A joint consensus:
Modern multimodal imaging shows these are distinct inflammatory chorioretinal diseases - with different biology, prognosis & treatment.
Precision in language = precision in care.
#Uveitis #WhiteDotSyndromes #Retina
UveitisCSG retweeted
Inflammatory bowel disease is not just a disease of the gut.
Joint pain, inflammatory back pain, enthesitis, dactylitis, uveitis, erythema nodosum, and even sacroiliitis may be the first clue to an underlying bowel disorder.
Recognizing IBD-associated arthritis early can prevent disability, improve quality of life, and help clinicians choose therapies that target both the gut and the joints.
Key takeaway:
Treat the gut and the joints together.
#IBD #Spondyloarthritis #Rheumatology #CrohnsDisease #UlcerativeColitis @IhabFathiSulima @drkeithsiau @docakx
🤖 Made with AI
UveitisCSG retweeted
#Vaccinations against #COVID, human #papillomavirus, #varicella, and #herpes #zoster were associated with a more than 50% reduced risk for developing new-onset #idiopathic #uveitis within 12 months. medscape.com/viewarticle/rou…

ALT #Vaccinations against #COVID, human #papillomavirus, #varicella, and #herpes #zoster were associated with a more than 50% reduced risk for developing new-onset #idiopathic #uveitis within 12 months. https://www.medscape.com/viewarticle/routine-vaccines-may-offer-protection-against-uveitis-2026a1000ma3
UveitisCSG retweeted
Last week’s Joint Uveitis NW Meeting at @WhitworthArt brought Liverpool & Manchester together beneath the waves, rain and landscapes of Hokusai and Hiroshige.
A fitting reminder that #uveitis, like art, is about layers, pattern recognition and seeing what lies beneath...
Thanks to our speakers and delegates.
#Inflammation #Ophthalmology
Why should you complete the Women in Retina Survey?
The panel discuss what has changed since 2021, why this updated survey matters, & why every voice - women and men alike - counts.
Take the Survey: ow.ly/mVbe50ZkZTS
Listen to the podcast: ow.ly/N8rz50ZkZTR
UveitisCSG retweeted
🔹 5 Key Therapeutic Considerations
#3 Pregnancy & systemic uveitis treatment: what’s safe?
Balancing disease control and fetal safety requires evidence-based, multidisciplinary care.
Rüegg et al. EULAR update (ARD 2025)
UveitisCSG retweeted
Tomorrow, uveitis meets the easel yet again in Manchester🎨👁️
Looking forward to the Joint Manchester–Liverpool #Uveitis Meeting at the @WhitworthArt Gallery, where we’ll brush up (😉) on imaging, frame tricky cases, and keep inflammation firmly in perspective.
UveitisCSG retweeted
Can choroidal thickness predict vision outcomes in uveitis? A new longitudinal study in @SciReports shows that higher baseline thickness is prognostic of better future visual acuity. Read more: pubmed.ncbi.nlm.nih.gov/4231…
Apply for The Ramin Tadayoni Award 2026!
Supporting excellence in retinal research, the award offers a €30,000 prize, plus €5,000 for the winning candidate.
🗓 DDL: 24 June 2026
👉 Apply: ow.ly/YGRW50Z5bwm
#Euretina26 #RetinaResearch #Ophthalmology
UveitisCSG retweeted
📢 A landmark consensus moment for the global #uveitis community 👁️
It is time to retire the term "White Dot Syndromes".
For decades, this phrase has acted as a convenient umbrella label for inflammatory chorioretinal disorders. But modern multimodal imaging, improved disease characterisation and better understanding of pathogenesis now show that these conditions are distinct entities - with different anatomy, prognosis, monitoring needs and treatment implications.
The Multimodal Imaging in Uveitis (MUV) Group, led by the International Uveitis Study Group, has brought together the wider global uveitis, ocular inflammation, retinal imaging and vitreoretinal communities around a simple but important message:
Retire the umbrella.
Name the disease.
Treat with precision.
Clearer terminology means better diagnosis, stronger research, more meaningful trials and ultimately better patient care.
#Uveitis #WhiteDotSyndromes #MultimodalImaging #OcularInflammation #PosteriorUveitis #Retina #RetinalImaging #Ophthalmology #PrecisionMedicine #ClinicalResearch #PatientCare































